HIV-1 drug mutations in children from northern Tanzania
Author(s) -
Elichilia R. Shao,
Emanuel Kifaro,
Innocent Chilumba,
Balthazar Nyombi,
Sikhulile Moyo,
Simani Gaseitsiwe,
Rosemary Musonda,
Asgeir Johannessen,
Gibson Kibiki,
Max Essex
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku087
Subject(s) - nevirapine , tanzania , drug resistance , genotype , medicine , hiv drug resistance , dried blood spot , virology , viral load , transmission (telecommunications) , pediatrics , reverse transcriptase , human immunodeficiency virus (hiv) , biology , gene , antiretroviral therapy , genetics , polymerase chain reaction , environmental science , environmental planning , electrical engineering , engineering
In resource-limited settings, it is a challenge to get quality clinical specimens due to poor infrastructure for their collection, transportation, processing and storage. Using dried blood spots (DBS) might be an alternative to plasma for HIV-1 drug resistance testing in this setting. The objectives of this study were to determine mutations associated with antiretroviral resistance among children <18 months old born to HIV-1-infected mothers enrolled in prevention of mother-to-child transmission services in northern Tanzania.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom